{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:09:54Z","timestamp":1758672594308,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jacbts.2025.101371","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T03:49:28Z","timestamp":1755748168000},"page":"101371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Implications of ErbB Pathway Modification in Heart Failure with Reduced Ejection Fraction"],"prefix":"10.1016","volume":"10","author":[{"given":"Senthil","family":"Selvaraj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Michael","family":"Felker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2025.101371_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamacardio.2024.0615","article-title":"Reversals in the decline of heart failure mortality in the US, 1999 to 2021","volume":"9","author":"Sayed","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacbts.2025.101371_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"HF STATS 2024: heart failure epidemiology and outcomes statistics an updated 2024 report from the Heart Failure Society of America","volume":"31","author":"Bozkurt","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacbts.2025.101371_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.011980","article-title":"Metabolic effects of the SGLT2 inhibitor dapagliflozin in heart failure across the spectrum of ejection fraction","volume":"17","author":"Selvaraj","year":"2024","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2025.101371_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.3709","article-title":"How to facilitate seamless translation from basic concepts to new heart failure drugs. A scientific statement of the Heart Failure Association of the ESC","author":"Tocchetti","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2025.101371_bib5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jaccao.2020.08.010","article-title":"How to follow, manage and treat cardiac dysfunction in patients with Her2+ breast cancer","volume":"2","author":"Blaes","year":"2020","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jacbts.2025.101371_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/CIRCULATIONAHA.109.856310","article-title":"Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure","volume":"120","author":"Ky","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2025.101371_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00395-005-0514-4","article-title":"Neuregulin receptors erbB2 and erbB4 in failing human myocardium\u2014depressed expression and attenuated activation","volume":"100","author":"Rohrbach","year":"2005","journal-title":"Basic Res Cardiol"},{"issue":"9","key":"10.1016\/j.jacbts.2025.101371_bib8","article-title":"Single ascending-dose study of selective ErbB4 agonist JK07 in heart failure with reduced ejection fraction","volume":"10","author":"Tang","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jacbts.2025.101371_bib9","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.ajpath.2019.06.008","article-title":"Mechanisms of receptor tyrosine-protein kinase ErbB-3 (ERBB3) action in human neoplasia","volume":"189","author":"Black","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacbts.2025.101371_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/eurjhf\/hfq152","article-title":"Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses","volume":"13","author":"Jabbour","year":"2011","journal-title":"Eur J Heart Fail"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X25003249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X25003249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:08:33Z","timestamp":1758614913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X25003249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2452302X25003249"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2025.101371","relation":{},"ISSN":["2452-302X"],"issn-type":[{"type":"print","value":"2452-302X"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Implications of ErbB Pathway Modification in Heart Failure with Reduced Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2025.101371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2025.101352","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101371"}}